CIBC Bancorp USA’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
CIBC Bancorp USA's TDOC Position: Q3 2026 in Review
CIBC Bancorp USA increased its Teladoc Health (TDOC) stake by 70% in Q3 2026, buying an estimated $56.8K and bringing the position to 18,840 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #2085.
CIBC Bancorp USA first reported a position in TDOC in Q3 2025 and has held it in 4 quarters since. The position peaked at $145K in Q3 2025. 324 funds tracked by Wall St. Rank hold TDOC as of Q3 2026.
- CIBC Bancorp USA held 18,840 shares of Teladoc Health worth $109K as of Q3 2026.
- CIBC Bancorp USA bought 7,770 Teladoc Health shares in Q3 2026, an estimated $56.8K.
- Teladoc Health made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #2085 holding.
- CIBC Bancorp USA first reported a position in Teladoc Health in Q3 2025 and has held it in 4 quarters since.
- CIBC Bancorp USA's Teladoc Health position peaked at $145K in Q3 2025.
- 324 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.